ITP
LLY icon

Iron Triangle Partners’s Eli Lilly LLY Stock Holding History

Iron Triangle Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$37.7M Sell
35,045
-14,510
-29% -$13.9M 4.31% 9
2025
Q3 		$37.8M Buy
+49,555
New +$36.9M 5.38% 6

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Iron Triangle Partners's LLY Position: Q4 2025 in Review

Iron Triangle Partners reduced its Eli Lilly (LLY) stake by 29% in Q4 2025, selling an estimated $13.9M and leaving 35,045 shares worth $37.7M. The position accounts for 4.31% of the portfolio, ranked #9.

Iron Triangle Partners first reported a position in LLY in Q3 2025 and has held it in 2 quarters since. The position peaked at $37.8M in Q3 2025. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Iron Triangle Partners held 35,045 shares of Eli Lilly worth $37.7M as of Q4 2025.
  • Iron Triangle Partners sold 14,510 Eli Lilly shares in Q4 2025, an estimated $13.9M.
  • Eli Lilly made up 4.31% of Iron Triangle Partners's portfolio in Q4 2025, its #9 holding.
  • Iron Triangle Partners first reported a position in Eli Lilly in Q3 2025 and has held it in 2 quarters since.
  • Iron Triangle Partners's Eli Lilly position peaked at $37.8M in Q3 2025.
  • 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Iron Triangle Partners's 13F filing for Q4 2025, filed 17 Feb 2026.